Search

everythinglearnresearchcommunity

for

Search:↓

Hair density and thickness decrease in all scalp areas for East Asians with AGA.

AGA might indicate higher risk for severe COVID-19.

PRP treatment improves hair count, density, and reduces hair loss in AGA patients.

People with androgenetic alopecia (AGA) have lower hair density and more single-hair units compared to those with normal scalps.

AGA causes hair loss through follicle miniaturization and hair cycle changes; regrowth depends on anagen initiation in kenogen follicles.

AGA treated with finasteride, minoxidil, and hair transplantation.

Reducing micro-inflammation didn't change hair growth patterns in AGA.

AGA is a genetic, hormonal hair loss treated with finasteride, minoxidil, and supplements, but new compounds are being developed.

Adipose stem cell-derived exosomes are safe and effective for hair regrowth in AGA patients.

Men with a certain type of hair loss (vertex type AGA) may have higher levels of bad fats (triglycerides) and lower levels of good cholesterol (HDL), suggesting they could be at risk for high fat levels in the blood (hyperlipidemia).

675 nm laser therapy effectively improves hair growth and density in AGA patients.

Higher IMA levels in male AGA patients, especially if obese, may link AGA to metabolic and heart issues.

Drugs like PDEI may help hair disorders like AGA.

Only anti-androgenic drugs likely halt AGA progression.

New method, hair distribution width (HDW), improves accuracy in diagnosing androgenetic alopecia (AGA).

FAPD and possibly CCCA may be AGA subtypes, and treatments combining antiandrogens, hair growth agents, hair transplants, and anti-inflammatories could be effective.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

AGA is a common hair loss disorder, and early diagnosis and treatment with minoxidil or finasteride can help reduce emotional distress.

Red fluorescence in AGA scalps is linked to different microbes.

Combining PRP with minoxidil significantly improves hair growth in AGA patients.

AGA patients have a lower quality of life than AA patients.

Eczema patients have a lower skin lipid to protein ratio, older and longer-staying hospital patients are more likely to get pressure ulcers, hair loss in AGA is linked to muscle degeneration, vitamin D deficiency is common in alopecia areata and linked to its severity, standard liver tests don't effectively detect fibrosis in psoriasis patients on methotrexate, and bullous pemphigoid patients have a higher death risk but combination therapy may reduce it.

Genetically repaired stem cells may treat certain genetic diseases, Th17 cells are key in fighting systemic fungal infections, hair loss in AGA is due to progenitor cell loss, and α-synuclein transfer might contribute to Parkinson's disease progression.

The conclusion is that more women in their forties are getting AGA and stress is linked to AGA in both men and women.

PRP treatment mildly to moderately improves hair loss in most men with AGA.

Androgenetic Alopecia (AGA) greatly lowers quality of life, causing stress and low self-esteem, with those seeking treatment experiencing more impairment.

AGA patients have higher insulin resistance and serum progranulin levels, suggesting a link to metabolic issues.

AGA patients have lower serum vaspin levels, which might help detect the condition early.

People with androgenic alopecia (AGA) have a higher chance of getting metabolic syndrome.

Thiol/disulfide balance is normal in male AGA patients but shifts towards oxidative stress with emotional stress and low vitamin D.